Hologic (HOLX) PT Raised to $43 at Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst Mark Massaro raised the price target on Hologic (NASDAQ: HOLX) to $43.00 (from $41.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
